|
|
Article: Commonly Used Blood Pressure Medication Prevents Aortic Aneurysm in Mice With Marfan Syndrome, Johns Hopkins Study Shows; Research Advances Likelihood of Clinical Treatment for Inherited Vascular Condition, Affirms Promise of Genetic Research.
- Article from:
- Ascribe Higher Education News Service
- Article date:
- April 6, 2006
CopyrightCOPYRIGHT 2006 AScribe. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Johns Hopkins Medical Institutions
BALTIMORE, April 6 (AScribe Newswire) -- Scientists at Johns Hopkins have used a commonly prescribed blood pressure medicine, losartan (Cozaar), to prevent a potentially fatal weakening of arteries in mice with Marfan syndrome.
As a result, efforts are already under way with the National Heart, Lung and Blood Institute and its affiliated network of hospitals in the Pediatric Heart Health Network and The Johns Hopkins Hospital to begin a clinical trial for people with Marfan syndrome, which is expected to start in the fall.
"The results of our study in mice greatly increase the likelihood that losartan ...